Stevens-Johnson syndrome, first reported in 1922, 1 is an acute inflammatory disease that predominantly aVects skin and mucosal membranes including the ocular surface. In the acute phase, ocular manifestations include corneal ulceration and severe pseudomembranous conjunctivitis. [2] [3] [4] [5] After the initial attack has passed, about half of the patients with severe systemic Stevens-Johnson syndrome continue to have ocular surface problems that include symblepharon, entropion, ectropion, trichiasis, dry eye, persistent conjunctival inflammation, conjunctival injection, and corneal opacification. 4 5 It is thought that the pathogenesis of Stevens-Johnson syndrome in the acute phase might be related to an immunological hypersensitivity to drugs or micro-organisms. [6] [7] [8] However, little is known about the persistent inflammation during chronic phase StevensJohnson syndrome. To better understand the immunopathogenesis of the corneal conjunctivalisation that is seen in Stevens-Johnson syndrome, we examined tissue from five patients with Stevens-Johnson syndrome who presented at Kyoto Prefectural University of Medicine Hospital between March and July 1995. We similarly examined conjunctivalised corneas from three chemically injured eyes.
Materials and methods
Resected tissues specimens were frozen sectioned (6 µm thick) and placed on glass slides. Immunohistochemical studies were performed by the standard ABC method. Cold acetone was used as fixative for the detection of LFA-1, CD4, CD8, CD19, CD68, HLA-DR, and ICAM-1 and 4% paraformaldehyde was used as fixative for the detection of IFN-and IL-4. To eliminate non-specific immune staining, 5% normal goat serum was used. All specimens were incubated overnight with the following primary antibodies at 4°C at the stated dilution (all were raised in mouse and purchased from Dako Corp (Glostrup, Denmark)): LFA-1 (1:200), CD4 (1:20), CD8 (1:200), CD19 (1:100), CD68 (1:100), HLA-DR (1:100), ICAM-1 (1:50). Antihuman IFN-(50 mg/ml) was purchased from Endogen (Cambridge, MA, USA) and the anti-human IL-4 (5 mg/ml) from Genzyme (Cambridge, MA, USA). For negative controls, normal mouse IgG was used instead of the primary antibody. Biotinylated rabbit antimouse immunoglobulin (Dako) was used as the secondary antibody, and specimens were incubated in it for 1 hour at a dilution of 1/800, followed by the incubation in the avidin-biotinperoxidase complex (Vector Laboratories Inc, Burlingame, CA, USA) at room temperature for 30 minutes. In developing, DAB buVered with 0.05 M TRIS buVer was used. Finally, sections were counterstained with methyl green.
Results and discussion
Before surgery, no inflammation was noted in patients 2 and 5, whereas patients 1, 3, and 4 occasionally presented with mild inflammation. However, these mild inflammatory episodes invariably resolved without the administration of extra medication.
On histological examination, conjunctivalised corneas from all patients with StevensJohnson syndrome were characterised by fairly extensive subepithelial mononuclear infiltration ( Fig 1A) . No polymorphonuclear cells (PMNs) were evident in any regions of the specimens except for the vascular lumen. The conjunctivalised corneal epithelium was clearly thicker than normal in four of the five cases.
All specimens showed positive immunohistochemical reactions for anti-LFA-1 ( Fig  1B) , anti-CD4 (Fig 1C) , anti-CD8 (Fig 1D) , anti-CD68 (Fig 1F) , anti-HLA-DR (Fig 1G) , and anti-ICAM-1 (Fig 1H) . HLA-DR and ICAM-1 immunoreactivities were detected on subepithelial infiltrating cells, epithelial cells and endothelial cells of blood vessels. LFA-1, CD4, CD8, and CD68 immunoreactivities were detected on subepithelial mononuclear infiltrating cells only. However, CD19 immunoreactivity was not detected in any of the patients (Fig 1E) . IFN-immunoreactivity was detected in subepithelial infiltrating cells, in the basal layer of the conjunctivalised corneal epithelium, and in endothelial cells of blood vessels (Fig 1I) . IL-4 immunoreactivity was not evident except for on PMNs in the blood vessel (Fig 1J) . Immunohistochemistry of conjunctivalised corneas from three chemically injured eyes (not shown) disclosed a similar pattern of cell surface antigen and cytokine immunoreactivity as did the conjunctivalised StevensJohnson syndrome corneas.
Stevens-Johnson syndrome is a self limited disease and many investigations have been done to elucidate the immunological mechanism of initial attack. [6] [7] [8] Clinically, however,
Figure 1 Representative serial sections from Stevens-Johnson conjunctiva (patient No 4). Immunohistochemical sections are stained by the ABC method with DAB (counterstained with methyl green). (A) Haematoxylin and eosin (HE). Conjunctivalised corneal epithelium moderately thickened and subepithelial infiltrating cells notable. (B) Anti-LFA-1. Many immunopositive cells seen in the substantia propria of the conjunctiva. (C) Anti-CD4. Immunopositive cells seen in the substantia propria of the conjunctiva. (D) Anti-CD8. Immunopositive cells seen in the substantia propria of the conjunctiva. (E) Anti-CD19. No positive staining is seen in this section except for some polymorphonuclear cells in the vascular lumen. (F) Anti-CD68. Many subepithelial infiltrating cells are immunostained. (G) Anti-HLA-DR. Basal cells of conjunctival epithelium, subepithelial infiltrating cells, and endothelial cells of blood vessels are immunostained. (H) Anti-ICAM-1. Basal cells of conjunctival epithelium, subepithelial infiltrating cells, and endothelial cells of blood vessels are weakly immunostained. (I) Anti-IFN-. Basal cells of conjunctival epithelium, subepithelial infiltrating cells, and endothelial cells of blood vessels are weakly immunoreactive. (J) Anti-IL-4. No positive staining is seen in this section except for some polymorphonuclear cells in the vascular lumen. (K) A negative control section incubated with IgG1 in lieu of a primary antibody. Scale bar (upper right) 100 µm.
we often see patients with Stevens-Johnson syndrome with slowly progressive conjunctivalisation of cornea and decline of visual acuity even when many years have passed after the initial attack. Also, the outcome of keratoplasty for patients with Stevens-Johnson syndrome is very poor compared with other corneal diseases. Before this study, we believed that both poor surgical outcome and chronically progressive conjunctivalisation are based on the specific immunopathogenesis of StevensJohnson syndrome. To our surprise, substantial inflammatory cell infiltration was observed in the five patients with Stevens-Johnson syndrome, despite little or no inflammation being noted clinically. In contrast with our preconceptions, the immunopathological features of conjunctivalised corneas in Stevens-Johnson syndrome are not appreciably diVerent from the immunopathological features of those in chemical injury. Also, within the group of five patients examined, the pattern of immunoreactivity to antibodies examined here was fairly consistent, and no clear correlation emerged between the immunopathological findings of an individual patient and the patients' clinical histories (Table 1) . Our results revealed that inflammatory cells in the substantia propria of conjunctivalised corneas of patients with Stevens-Johnson syndrome are composed of CD4 positive T cells, CD8 positive T cells, and/or macrophages. B lymphocytes are probably not present. In addition to this, we tried to identify CD4 positive T cells from the cytokine expression pattern. Our results revealed the predominance of IFN-suggesting that CD4 positive T cells were mainly Th1 cells that can promote cellular immunity. 9 Interestingly, Foster and associates, in their immunohistochemical study of two patients with Stevens-Johnson syndrome who experienced recurrent episodes of inflammation, found that the predominant T cells in conjunctiva were T helper cells, rather than suppressor T cells which usually outnumber T helper cells in normal conjunctiva. 10 These authors also found HLA-DR positive cells in the epithelium and substantia propria of conjunctiva that they identified as Langerhans cells, macrophages, and activated T cells. Though their results are similar to ours, the clinical types of patients they examined are apparently diVerent from ours. However, the diVerence between patients with Stevens-Johnson syndrome who experience recurrent episodes of conjunctival inflammation and those who don't is not readily evident.
A similar immunostaining pattern between Stevens-Johnson syndrome and chemical injury corneas suggests that inflammatory cell infiltration in the substantia propria of patients with Stevens-Johnson syndrome may not be a primary reaction but a secondary reaction from other ocular abnormalities related to stem cell failure such as trichiasis or severe dry eye. We feel that these pre-existing infiltrating cells at surgery may play an important part in graft rejection and/or post-surgically induced inflammation in patients with Stevens-Johnson syndrome. 
